<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Padiham Group Practice</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Padiham Group Practice is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0205040V0&amp;denomIds=2.5.4&amp;selectedTab=summary">Terazosin hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>62</td>
      <td>Alpha-adrenoceptor blocking drugs</td>
      <td>754</td>
      <td>0.08</td>
      <td>0.01</td>
      <td>0.01</td>
      <td>5.39</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAFYklEQVR4nO3dW6gVVRzH8e9Ku4ndlJQEYSjqxe5WYJpZRAgjJQUF9tSL1UtENzfYSxdiIgKJKKgQ6q0iKGpDpajZgz5oKGU3fBgJIk55yvSopfbvYY24O5x9zt6etWaPrt8Hhn2c2Xv9Z23nN7c9zDgzQ0TScMagZ0BE6qPAiyREgRdJiAIvkhAFXiQhCrxIQhR4kYQo8CIJUeBFEqLAiyREgT8dOafrpWVMU0M1lLXa9wMPAivKIh8O1a6IhBNyC383cCZwU8A2RSSgYIEvi3wF8AlwQ6g2RSSs0Mfw24D5gdsUkUBCB34HcF3gNkUkkKCBL4v8AHAwa7VnhWxXRMKI8bOcdutFGipG4LejE3cijRQr8NrCizRQjMDvAK6N0K6ITFLwwFcn7kayVnt26LZFZHJiXUuv3XqRBooVeJ2pF2mgmFt4nakXaZhYgdeJO5EGihL4sshHgP1Zqz0nRvsicnJi3gBjM7A4Yvsi0qeYgd8E3BaxfRHpU+zA3xqxfRHpU7TAl0U+BBzVcbxIc8S+ieUmtFsv0hixA78RWBK5hoj0KHbgv0TH8SKNETXwZZH/DhzOWu25MeuISG/qeBCFdutFGkKBF0lIHYHfjI7jRRoheuCrx07tzVrtW2LXEpHx1fUwyUeAtVmrPbOmeiIyhloCXxb518Aa4J2s1dYTa0UGpM7wvQ4cAh6vsaaIdHBm9T1KPGu1LwC2AF8Br5ZFvqu24ilxzjBzg54NaZ5aAw+QtdrnAiuAR4HfgA+Az8oi31PrjJzOFHjpovbAH5e12g64GbgLWIp/tvwW/P3wtgM7yyI/PJCZO9Up8NLFwAI/WtZqXwLciL/55XzgamAvPvzfAN8Cu4BfyyJvxkw3lQIvXTQm8KNVewBz8OG/shrmAbOBYWAPMIRfKYwe9gEHgP3V64GyyP+tuQuDo8BLF40NfDfViuAiIANmATM7hhnV6/nAdOC86nU6J36ROAb8DRzu8noEODpqODbGuG7jj487voKxjlebYNxE03saV7607L1s1af3RajXq1P9/Sf7mYEoi3x9z282syADsDJUW6qruqobZwj5O/zKgG2pruqqbgS66k0kIQq8SEJCBv7NgG2pruqqbgSn3Fl6ETl52qUXScjUft7snFuMvxx2yMzWOufuAS4DduOvgnsA+AN4DXih+thqMzs2mZmcoO6f1bT9+LvrrAS+MLOPJlOzh7qGvypwA7ATeBI4ZGbPRa77M7Comv4icfu7HFhqZg93TgM+Jm5/O+suxz+J+CfgINV3bmYbItd9DL9B3Az8RbVsm9mayHVvx19lOg9oE7C/0P8WfoGZFcDF1b8vN7OXgSuAHB/ys4FrgHXA+urvyepa18w2AgX+gpt/8MGfFqDmuHWBEfxFOufg79n3NvCLc25GzLpmtg14H3+vwKj9rVYi5RjTlhCxv511q79fAeby/+88hPH6Owychd8odi7bUetWwd6KX6mG7m/fgR99wF/XCYCJ6j4NvGVm35nZKuDS2HXNbJ2ZPQtcH6hWT3Ur9wIf1tDfXqdFq+ucm4L//30jwnfeta6ZvVuF8o5AtXqqW7kT+DzGMtbXLj2w1Tm3Chh2zs0HdjvnngJ+BL4HVuN36XcCz1efeSbAfHat65x7CL/AL3DO/QAsA6YEqDlR3UX4Ld0+/CO1nsDv4g7HrFtNn21mQ865q4jb32nAQufcwo5pQ8Tvb2fdHL+cLnDOjXDiOw9hvLoX4nendwPbOLFsx667FTjDzI6MWsaC0Fl6kYToLL1IQhR4kYQo8CIJUeBFEqLAiyREgRdJiAIvkhAFXiQhCrxIQhR4kYQo8CIJ+Q/OIyoA4NdexgAAAABJRU5ErkJggg=="></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0205040V0AAACAC&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Terazosin 5mg tablets : 28</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0205040V0AAABAB&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Terazosin 2mg tablets : 10</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0205040V0AAADAD&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Terazosin 10mg tablets : 24</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=1202010M0&amp;denomIds=12.2.1&amp;selectedTab=summary">Fluticasone propionate (Nasal)</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>289</td>
      <td>Drugs used in nasal allergy</td>
      <td>555</td>
      <td>0.52</td>
      <td>0.13</td>
      <td>0.07</td>
      <td>5.33</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=1202010M0AAACAC&amp;denomIds=12.2.1&amp;selectedTab=summary" target="_blank">Fluticasone propionate 50micrograms/dose nasal spray : 271</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=1202010M0BBACAC&amp;denomIds=12.2.1&amp;selectedTab=summary" target="_blank">Flixonase 50micrograms/dose aqueous nasal spray : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=1202010M0AAABAB&amp;denomIds=12.2.1&amp;selectedTab=summary" target="_blank">Fluticasone 400microgram/unit dose nasal drops : 5</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=1202010M0BCAAAC&amp;denomIds=12.2.1&amp;selectedTab=summary" target="_blank">Nasofan 50micrograms/dose aqueous nasal spray : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0802010N0&amp;denomIds=8.2.1&amp;selectedTab=summary">Mycophenolic sodium</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>8</td>
      <td>Antiproliferative immunosuppressants</td>
      <td>69</td>
      <td>0.12</td>
      <td>0.01</td>
      <td>0.03</td>
      <td>4.25</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0802010N0BBAAAA&amp;denomIds=8.2.1&amp;selectedTab=summary" target="_blank">Myfortic 180mg gastro-resistant tablets : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0802010N0BBABAB&amp;denomIds=8.2.1&amp;selectedTab=summary" target="_blank">Myfortic 360mg gastro-resistant tablets : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=1203040C0&amp;denomIds=12.3.4&amp;selectedTab=summary">Cetylpyridinium chloride</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Mouth-washes, gargles and dentifrices</td>
      <td>20</td>
      <td>0.10</td>
      <td>0.00</td>
      <td>0.03</td>
      <td>3.50</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAD/UlEQVR4nO3dP4gcZRzG8e8btckhYqGdZkhMCgWJWEj8EyyVVZBgbyEEQRFsdEs7VxQbUwQLUVsRxbjGQlSM0bOIjU0wQdZSQSMIIf6JP4tb9W499ebmfZ1Z3+8Hjt3bm3vvuR2ee9+Z3dtNEYGkOuzoO4Ck/46Flypi4aWKWHipIhZeqoiFlypi4aWKWHipIhZeqoiFlyry/yx8Sj5fWNpEp8I34+mzzXh6ba4wksrqOsM/DNycI4ik8roW/jJgb44gksrrWvhXsfDS0uha+CNYeGlpdC38KWBPjiCSyutU+NlkdAG42IynK5nySCoox+PwZ4HrMowjqbAchT+Dx/HSUshVeGd4aQk4w0sVsfBSRXIU/ktgd4ZxJBXWufCzyegn4MdmPL08Qx5JBeX691gfmpOWQK7CexwvLQELL1XEwksVsfBSRXIVfgY0mcaSVEiWws8mo5+B8814ekWO8SSVkfNVa13WSwOXs/Cngeszjicps5yF/xi4PeN4kjLLWfgTwB0Zx5OUWbbCzyajr4HUjKdX5xpTUl6532rKWV4asNyF/xA4mHlMSZmUKLwzvDRQWQs/m4y+Aq70CTjSMJV4u+iTwG0FxpXUUYnCu6yXBqpE4U/giTtpkEoU/jSwqxlPdxYYW1IH2Qs/m4wC+BS4JffYkropMcMDHAeea8bTQ814ekmhnyGppRQRRQZuxtMDwGPAfuA14BzwA3B+vskOIK27XLwewEXgl/nl+o/fb/t1vt0Gs6fvOdY88da9fxNtO79wtLy+ne8psyOWQ2p5+3a/lnu8Rf+2b9t8fctmk9F7W922U+FTSocj4oVtD1CIudobajZz5dV1SX84S4r8zNXeULOZK6NSx/CSBsjCSxXpWvihHsOYq72hZjNXRsXO0ksaHpf0UkUubbNxSukgcCvwTUS8mFI6BOwBzkbE6yUCdsh2H3BXRDw0sFwPADcAxyPi/QHluhu4Cfg8Io4NJdf8tqPASxGx2leuzbKllJ4Evgfejogv+sy2VW1n+AMRMQGumn++NyKeAfbljbUtG7JFxBusvSNO3xZzvQwcBXb3muqv+3IVuAa40F8kYCHXfFL5oNdEf1q8z74FVnrM01rbwv/Ts8n6NqQs623IlVJaAR4EXuknzh825IqIc8Aj9P+HaHE/3sjay58P4TUWFu+z54GngPv7idNeq5N28yXNAeA74DNgF2tL+jPzGbU3m2TbCTwOTCLi5IByPQqcBd6NiE8GlGs/a/tyNSLeHEquiDiVUroTuDCQJf36+2wfa4dnH0XEO31m2yrP0ksV8Sy9VBELL1XEwksVsfBSRSy8VBELL1XEwksVsfBSRSy8VBELL1XEwksV+Q2N4jtxq6K6vwAAAABJRU5ErkJggg=="></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=1203040C0BDAAAC&amp;denomIds=12.3.4&amp;selectedTab=summary" target="_blank">Anbesol liquid : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=120304000&amp;denomIds=12.3.4&amp;selectedTab=summary">Other mouth wash, gargle and dentifrice preparations</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Mouth-washes, gargles and dentifrices</td>
      <td>20</td>
      <td>0.10</td>
      <td>0.00</td>
      <td>0.03</td>
      <td>3.43</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=120304000BBCPA0&amp;denomIds=12.3.4&amp;selectedTab=summary" target="_blank">UltraDEX Oral Rinse : 2</a></div></td></tr></tbody></table>

        <h2>Prescribing where Padiham Group Practice is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0205040D0&amp;denomIds=2.5.4&amp;selectedTab=summary">Doxazosin mesilate</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>692</td>
      <td>Alpha-adrenoceptor blocking drugs</td>
      <td>754</td>
      <td>0.92</td>
      <td>0.99</td>
      <td>0.02</td>
      <td>-3.69</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0205040D0AAAAAA&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 1mg tablets : 151</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0205040D0AAABAB&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 2mg tablets : 156</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0205040D0AAACAC&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 4mg tablets : 327</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0205040D0AAARAR&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 8mg modified-release tablets : 31</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0205040D0AAAQAQ&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 4mg modified-release tablets : 12</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0205040D0AABBBB&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 8mg tablets : 15</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=1001022K0&amp;denomIds=10.1.2&amp;selectedTab=summary">Methylprednisolone acetate</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Local corticosteroid injections</td>
      <td>25</td>
      <td>0.00</td>
      <td>0.73</td>
      <td>0.39</td>
      <td>-1.87</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0901011F0&amp;denomIds=9.1.1&amp;selectedTab=summary">Ferrous fumarate</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>84</td>
      <td>Oral iron</td>
      <td>606</td>
      <td>0.14</td>
      <td>0.57</td>
      <td>0.24</td>
      <td>-1.85</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0901011F0AAAEAE&amp;denomIds=9.1.1&amp;selectedTab=summary" target="_blank">Ferrous fumarate 210mg tablets : 65</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0901011F0AAAIAI&amp;denomIds=9.1.1&amp;selectedTab=summary" target="_blank">Ferrous fumarate 140mg/5ml oral solution sugar free : 19</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0304010I0&amp;denomIds=3.4.1&amp;selectedTab=summary">Cetirizine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>85</td>
      <td>Antihistamines</td>
      <td>917</td>
      <td>0.09</td>
      <td>0.28</td>
      <td>0.11</td>
      <td>-1.77</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0304010I0AAAAAA&amp;denomIds=3.4.1&amp;selectedTab=summary" target="_blank">Cetirizine 10mg tablets : 61</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=0304010I0AAABAB&amp;denomIds=3.4.1&amp;selectedTab=summary" target="_blank">Cetirizine 1mg/ml oral solution sugar free : 24</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=1106000AF&amp;denomIds=11.6&amp;selectedTab=summary">Bimatoprost</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>16</td>
      <td>Treatment of glaucoma</td>
      <td>1434</td>
      <td>0.01</td>
      <td>0.11</td>
      <td>0.06</td>
      <td>-1.68</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=1106000AFAAABAB&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Bimatoprost 100micrograms/ml eye drops : 11</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81130&amp;numIds=1106000AFAAADAD&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Bimatoprost 300micrograms/ml eye drops preservative free : 5</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>